Slide Shows

Module 1: Understanding AML

Understanding AML
This slide show provides an overview of acute myeloid leukemia (AML), a blood and bone marrow cancer that happens to persons who have too many abnormal cells called myeloblasts. It describes the causes, risk factors, and symptoms of AML, as well as the subtype of AML called acute promyelocytic leukemia (commonly referred to as APL or APML).
View now

Module 2: Understanding AML-MRC and tAML

Understanding AML-MRC and tAML
This slide show provides an overview of acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) and treatment-related acute myeloid leukemia (tAML). It also describes the causes, risk factors, and symptoms of AML-MRC and tAML. Both AML-MRC and tAML are “secondary” types of AML because they occur after a person has had MDS or another type of cancer. AML that starts abruptly with no known prior exposure to chemotherapy or radiation and no prior cancer diagnosis is called “de novo” AML and is discussed in another segment in this series.
View now

Module 3: Diagnosing AML, AML-MRC, and tAML

Diagnosing AML, AML-MRC, and tAML
This slide show explains the tests that doctors use to diagnose acute myeloid leukemia (AML), AML with myelodysplasia-related changes (AML-MRC) and treatment-related AML (tAML). It describes the examination, blood tests, bone marrow tests, genetic tests, imaging tests, and other diagnostic interventions. These tests may be ordered to help identify what subtype of AML a person has and whether it has spread outside of the blood and bone marrow.
View now

Module 4: Treating AML

Treating AML
This slide show explains the current treatments for acute myeloid leukemia (AML). It also explains key terms used in AML treatment such as complete remission, measurable residual disease (MRD), hematologic recovery, cytogenetic response, and molecular response. Treatment options are described, such as induction chemotherapy, consolidation chemotherapy, stem cell transplant, and targeted therapy. It’s important to discuss all treatment options with your doctor or cancer care team, so you can make the best decisions that are right for you.
View now

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.